Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Executive V.P., Operations | June 04, 2007 | June 05, 2007 |
| ANAPTYSBIO, INCANAB · Entity 4640 | Director | January 06, 2026 | January 08, 2026 |
| First Tracks Biotherapeutics, Inc.TRAX · Entity 4696 | Director | June 15, 2026 | June 17, 2026 |
| Pfenex Inc.PFNX · Entity 146052 | Director | May 05, 2017 | May 08, 2017 |
| Sienna Biopharmaceuticals, Inc.SNNA · Entity 154554 | Director | May 30, 2019 | June 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date June 04, 2007 · Filed June 05, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 132,661 |
Reported balance
After 2007-06-04 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2007-06-04 · Exercise / conversion · Acquired 10,000 · Balance 132,661 |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 127,518 |
Reported balance
After 2007-06-04 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2007-06-04 · Sale · Disposed 5,143 · Balance 127,518 |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trust | 117,518 |
Reported balance
After 2007-06-04 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2007-06-04 · Sale · Disposed 10,000 · Balance 117,518 |
| NQSOSEC Table II · derivative / convertible security · Conversion / exercise price $38.36 · Expires 2009-07-01 | IndirectBy Family Trust | 27,391 |
Reported balance
After 2007-06-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2007-06-04 · Exercise / conversion · Disposed 10,000 · Balance 27,391 F1: This option exercisable as follows: 30,000 shares on July 1, 2003; 30,000 shares on July 1, 2004; 30,000 shares on July 1, 2005; 30,000 shares on July 1, 2006; and 27,391 shares in July 1, 2007. |
| Common StockSEC Table I · non-derivative | Direct | 6,668 |
Reported balance
Holding disclosure · report date 2007-06-04 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,668 |
| Common StockSEC Table I · non-derivative | IndirectBy Irrevocable Trust | 1,000 |
Reported balance
Holding disclosure · report date 2007-06-04 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This option exercisable as follows: 30,000 shares on July 1, 2003; 30,000 shares on July 1, 2004; 30,000 shares on July 1, 2005; 30,000 shares on July 1, 2006; and 27,391 shares in July 1, 2007.
ANAPTYSBIO, INC
Report date January 06, 2026 · Filed January 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.91 · Expires 2036-01-05 | Direct | 5,500 |
Reported balance
After 2026-01-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-06 · Grant · Acquired 5,500 · Balance 5,500 F1: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 4,000 |
Reported balance
After 2026-01-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-06 · Grant · Acquired 4,000 · Balance 4,000 F2: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F3: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
First Tracks Biotherapeutics, Inc.
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,995 |
Reported balance
After 2026-06-15 transaction · row 1
1 source rowRow 1 · 2026-06-15 · Exercise / conversion · Acquired 6,030 · Balance 10,995 F1: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-15 · Exercise / conversion · Disposed 6,030 · Balance 0 F1: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2: The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2: The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Pfenex Inc.
Report date May 05, 2017 · Filed May 08, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.92 · Expires 2027-05-05 | Direct | 18,000 |
Reported balance
After 2017-05-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-05 · Grant · Acquired 18,000 · Balance 18,000 F1: One hundred percent (100%) of the shares subject to the option shall vest and become exercisable on the date of the next annual meeting of the Issuer's stockholders (the "Annual Meeting") held after May 5, 2017, subject to the reporting person's continuing service through the date of the Annual Meeting. Notwithstanding the foregoing, one hundred percent (100%) of the shares subject to the option shall vest and become exercisable as of immediately prior to a Change in Control (as such term is defined in the Issuer's 2014 Equity Incentive Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: One hundred percent (100%) of the shares subject to the option shall vest and become exercisable on the date of the next annual meeting of the Issuer's stockholders (the "Annual Meeting") held after May 5, 2017, subject to the reporting person's continuing service through the date of the Annual Meeting. Notwithstanding the foregoing, one hundred percent (100%) of the shares subject to the option shall vest and become exercisable as of immediately prior to a Change in Control (as such term is defined in the Issuer's 2014 Equity Incentive Plan).
Sienna Biopharmaceuticals, Inc.
Report date May 30, 2019 · Filed June 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.22 · Expires 2029-05-30 | Direct | 25,000 |
Reported balance
After 2019-05-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-30 · Grant · Acquired 25,000 · Balance 25,000 F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, subject to continued service through each applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PORTOLA PHARMACEUTICALS INC
Report date July 02, 2020 · Filed July 02, 2020
Section 16 reporting ended · disclosed 2020-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 1
1 source rowRow 1 · 2020-07-02 · Disposition to issuer · Disposed 13,194 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the "Issuer"), Alexion Pharmaceuticals, Inc. ("Alexion") and Odyssey Merger Sub Inc. ("Merger Sub") (the "Merger Agreement"), on July 2, 2020, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the "Merger"). At the effective time of the Merger (the "Effective Time"), these shares were canceled in exchange for $18.00 per share in cash, without interest and subject to any applicable withholding taxes. |
| Restricted Stock UnitsSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 2
1 source rowRow 2 · 2020-07-02 · Disposition to issuer · Disposed 7,281 · Balance 0 F2: At the Effective Time, each restricted stock unit ("RSU") was accelerated and canceled as of immediately prior to, and contingent upon, the Effective Time, in exchange for the right to receive a cash amount equal to the product of (i) the number of shares deliverable under such RSU multiplied by (ii) $18.00. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.94 · Expires 2030-06-11 | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-07-02 · Disposition to issuer · Disposed 11,377 · Balance 0 F3: At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-07-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-07-02 · Disposition to issuer · Disposed 44,991 · Balance 0 F4: In connection with the Merger, these options were accelerated and canceled without payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the "Issuer"), Alexion Pharmaceuticals, Inc. ("Alexion") and Odyssey Merger Sub Inc. ("Merger Sub") (the "Merger Agreement"), on July 2, 2020, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the "Merger"). At the effective time of the Merger (the "Effective Time"), these shares were canceled in exchange for $18.00 per share in cash, without interest and subject to any applicable withholding taxes.
F2: At the Effective Time, each restricted stock unit ("RSU") was accelerated and canceled as of immediately prior to, and contingent upon, the Effective Time, in exchange for the right to receive a cash amount equal to the product of (i) the number of shares deliverable under such RSU multiplied by (ii) $18.00.
F3: At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law.
F4: In connection with the Merger, these options were accelerated and canceled without payment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2004 Filed Dec 7, 2004 01:25 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-057058 · rrd60344.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| November 18, 2004 Filed Nov 19, 2004 00:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-054055 · rrd58668.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 27,896 Underlying: Common Stock · 20,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2004 Filed Nov 19, 2004 00:27 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $59.99 | $1,199,800.00 |
DisclosureSEC source: 0001181431-04-054055 · rrd58668.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,752 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO(Right to Buy) · Derivative | 20,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · derivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 47,896 Underlying: Common Stock · 20,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $59.12 | $1,182,312.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,752 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $16.38 | $327,500.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 127,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 12, 2004 Filed Nov 15, 2004 15:19 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-052639 · rrd57900.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,752 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| October 29, 2004 Filed Nov 1, 2004 17:59 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-049749 · rrd56183.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 67,896 Underlying: Common Stock · 20,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2004 Filed Nov 1, 2004 17:59 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $56.07 | $1,121,400.00 |
DisclosureSEC source: 0001181431-04-049749 · rrd56183.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 108,172 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| October 29, 2004 Filed Nov 1, 2004 17:59 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $16.38 | $327,500.00 |
DisclosureSEC source: 0001181431-04-049749 · rrd56183.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 128,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| September 03, 2004 Filed Sep 7, 2004 16:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-043082 · rrd52222.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 87,896 Underlying: Common Stock · 20,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2004 Filed Sep 7, 2004 16:27 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $59.61 | $1,192,200.00 |
DisclosureSEC source: 0001181431-04-043082 · rrd52222.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 108,172 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| September 03, 2004 Filed Sep 7, 2004 16:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $16.38 | $327,500.00 |
DisclosureSEC source: 0001181431-04-043082 · rrd52222.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 128,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| August 19, 2004 Filed Aug 20, 2004 16:58 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 880 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-041037 · rrd51003.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 108,172 F1 · balance_after: (DMF 08/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| August 18, 2004 Filed Aug 18, 2004 23:29 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-040808 · rrd50907.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 107,896 Underlying: Common Stock · 25,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2004 Filed Aug 18, 2004 23:29 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 25,000 | $57.09 | $1,427,200.00 |
DisclosureSEC source: 0001181431-04-040808 · rrd50907.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 109,052 F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| August 18, 2004 Filed Aug 18, 2004 23:29 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 25,000 | $16.38 | $409,375.00 |
DisclosureSEC source: 0001181431-04-040808 · rrd50907.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 134,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSD (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · derivative · entry 10 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 132,896 Underlying: Common Stock · 30,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 2 | $0.00 Strike: $38.36 | $0.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · derivative · entry 9 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,607 Underlying: Common Stock · 2 shares Expires 2009-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: (DMF 7.27.04) The option becomes exercizable as follows: 1 share on July 1, 2005; and 2,606 shares on July 1, 2007. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 3,284 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · derivative · entry 8 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,284 shares Expires 2006-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 26,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · nonDerivative · entry 7 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 109,052 F2 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 30,000 | $56.11 | $1,683,300.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · nonDerivative · entry 6 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 135,881 F2 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 3,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · nonDerivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 165,881 F1 · kind: (DMF 7.27.04) Transfer of shares into the Family Trust. F2 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $16.38 | $491,250.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · nonDerivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 162,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 3,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: (DMF 7.27.04) Transfer of shares into the Family Trust. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 3,284 | $30.44 | $99,956.75 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2004 Filed Jul 28, 2004 17:56 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2 | $38.36 | $76.72 |
DisclosureSEC source: 0001181431-04-037401 · rrd49057.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex. VP Ops & Corp. Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 73,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016006 · rrd36779.xml · derivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,319 Underlying: Common Stock · 73,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016006 · rrd36779.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 02, 2004 Filed Mar 3, 2004 17:58 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-04-013334 · rrd35388.xml · derivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 162,896 Underlying: Common Stock · 15,000 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2004 Filed Mar 3, 2004 17:58 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 15,000 | $64.75 | $971,224.50 |
DisclosureSEC source: 0001181431-04-013334 · rrd35388.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 132,595 F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| March 02, 2004 Filed Mar 3, 2004 17:58 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 15,000 | $16.38 | $245,625.00 |
DisclosureSEC source: 0001181431-04-013334 · rrd35388.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 147,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| February 17, 2004 Filed Feb 18, 2004 18:55 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-010451 · rrd33628.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 132,595 F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 18:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 16,092 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001181431-04-004885 · rrd30536.xml · derivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 16,092 shares Expires 2004-12-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 18:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 16,092 | $64.66 | $1,040,508.72 |
DisclosureSEC source: 0001181431-04-004885 · rrd30536.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 132,795 F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 18:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,092 | $13.09 | $210,705.43 |
DisclosureSEC source: 0001181431-04-004885 · rrd30536.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 148,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| January 27, 2004 Filed Jan 28, 2004 18:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $64.66 | $646,600.00 |
DisclosureSEC source: 0001181431-04-004885 · rrd30536.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 132,795 F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| January 18, 2004 Filed Nov 19, 2004 00:27 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $16.38 | $327,500.00 |
DisclosureSEC source: 0001181431-04-054055 · rrd58668.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 127,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 8/04) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:34 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001181431-03-031435 · rrd22970.xml · derivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 16,092 Underlying: Common Stock · 20,000 shares Expires 2004-12-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:34 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-031435 · rrd22970.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 142,390 F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:34 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $59.40 | $1,188,000.00 |
DisclosureSEC source: 0001181431-03-031435 · rrd22970.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 142,820 F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 22:34 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $13.09 | $261,876.00 |
DisclosureSEC source: 0001181431-03-031435 · rrd22970.xml · nonDerivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 162,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 11/03) Does not include 1,000 shares indirectly held by the Irrevocable Trust. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · derivative · entry 9 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 36,092 Underlying: Common Stock · 30,000 shares Expires 2004-12-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionISO (Right to Buy) · Derivative | 6,104 | $0.00 Strike: $16.38 | $0.00 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · derivative · entry 8 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,104 shares Expires 2005-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · nonDerivative · entry 7 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct · By Family Trust Disclosed balance after: 143,255 F1 · shares: (DMF 7/31/03) Includes 6,104 shares transferred by the reporting person to the family trust. F1 · balance_after: (DMF 7/31/03) Includes 6,104 shares transferred by the reporting person to the family trust. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 15,000 | $70.06 | $1,050,825.00 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · nonDerivative · entry 6 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 137,121 F1 · balance_after: (DMF 7/31/03) Includes 6,104 shares transferred by the reporting person to the family trust. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 10,000 | $70.65 | $706,500.00 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · nonDerivative · entry 5 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 152,121 F1 · balance_after: (DMF 7/31/03) Includes 6,104 shares transferred by the reporting person to the family trust. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 15,320 | $70.64 | $1,082,204.80 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · nonDerivative · entry 4 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 162,121 F1 · balance_after: (DMF 7/31/03) Includes 6,104 shares transferred by the reporting person to the family trust. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $13.09 | $392,814.00 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · nonDerivative · entry 3 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 177,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: (DMF 7/31/03) Includes 6,104 shares transferred by the reporting person to the family trust. Read SEC document |
| July 31, 2003 Filed Aug 1, 2003 18:16 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-016676 · rrd14798.xml · nonDerivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: (DMF 7/31/03) Includes 6,104 shares transferred by the reporting person to the family trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.